How much did Novo Nordisk have to spend on this failed trial?
Now, if it had succeeded, how much MORE do they have to spend to get it approved and produced for Alzheimer’s patients?
Finally how much would it cost for a patient so that companies like Novo Nordisk can recoup their cost?
They’re trying to make it up in volume...
“How much did Novo Nordisk have to spend on this failed trial?”
Perhaps nothing. I know a guy in Venture Capital, he’s a bio-scientist. Gets sent to places like Novo to see if the Big Wallets want put up front money for the research and approval process in return for a piece of the drug profits. He threw out $20mm as a typical buy-in. Some never get approved, those are losses.